Yes, Down syndrome can be detected during pregnancy through a combination of screening and diagnostic tests. Screening tests, available as early as 10 weeks into pregnancy, estimate the likelihood that a baby has Down syndrome. Diagnostic tests can confirm it with near-complete certainty. Understanding the difference between these two categories, and when each is offered, helps you make informed choices about your prenatal care.
Screening Tests vs. Diagnostic Tests
Prenatal testing for Down syndrome falls into two distinct categories, and the difference matters. Screening tests estimate your risk level. They can flag a higher chance that your baby has Down syndrome, but they cannot confirm it. Diagnostic tests analyze the baby’s actual chromosomes and give a definitive yes or no answer.
Most people start with a screening test. If that result comes back positive or shows elevated risk, you then decide whether to follow up with a diagnostic test. Some people skip screening entirely and go straight to a diagnostic test, particularly if they already have a known risk factor like older maternal age. Neither path is mandatory, and the choice is yours at every step.
First Trimester Screening: Weeks 11 to 14
The earliest screening typically happens between 11 and 14 weeks of pregnancy and combines a blood test with a specialized ultrasound called a nuchal translucency (NT) measurement. This ultrasound measures the thickness of a small fluid-filled space at the back of the baby’s neck. All babies have this space, but a thicker-than-normal measurement can signal a higher chance of chromosomal conditions including Down syndrome.
The typical NT measurement ranges from about 1.0 to 1.65 millimeters depending on the baby’s size, with the 95th percentile falling between 1.8 and 2.35 millimeters. Measurements above the 95th percentile, and especially those above 3.5 millimeters, are associated with a significantly higher risk of chromosomal abnormalities. The ultrasound alone isn’t enough to diagnose anything. It’s combined with blood markers to produce an overall risk estimate.
Cell-Free DNA Screening (NIPT)
Cell-free DNA screening, commonly called NIPT (noninvasive prenatal testing), is a blood test that can be done as early as 10 weeks. It works by analyzing tiny fragments of the baby’s DNA that circulate in the mother’s bloodstream. For Down syndrome specifically, NIPT is remarkably accurate: studies report sensitivity of 100% (meaning it catches virtually all cases) with a specificity of about 99.9%.
Those numbers sound almost perfect, but there’s an important nuance. A positive NIPT result does not guarantee your baby has Down syndrome. A meta-analysis covering more than 750,000 NIPT tests found that roughly 9.8% of positive results for Down syndrome were false positives. That means about 1 in 10 people who get a positive NIPT result for Down syndrome are actually carrying a baby without the condition. The false positive rate is even higher for rarer chromosomal conditions. This is why medical guidelines are clear: a positive NIPT result should always be confirmed with a diagnostic test before making any decisions.
False positives can happen for several reasons, including fragments of placental DNA that don’t match the baby’s actual chromosomes, a vanishing twin from very early in the pregnancy, or even rare chromosomal changes in the mother herself.
Second Trimester Screening: The Quad Screen
If you missed first trimester screening or want additional information, a second trimester blood test called the quad screen is typically offered between 15 and 22 weeks. This test measures four substances in your blood and uses those levels, along with your age and other factors, to calculate a risk estimate. In a large study of nearly 40,000 pregnancies, the quad screen detected about 81% to 88% of Down syndrome cases, with a false positive rate around 7%. That makes it less accurate than NIPT, but it remains a useful option, particularly in settings where NIPT isn’t available or covered by insurance.
Diagnostic Tests: CVS and Amniocentesis
When you want a definitive answer, two diagnostic procedures can confirm whether a baby has Down syndrome by directly analyzing the baby’s chromosomes.
Chorionic villus sampling (CVS) is performed between 10 and 12 weeks of pregnancy. A small sample of tissue is taken from the placenta, which shares the baby’s genetic makeup. Amniocentesis is typically done between 15 and 18 weeks and involves collecting a small amount of the amniotic fluid surrounding the baby. Both procedures provide a clear chromosomal picture and are considered the gold standard for diagnosis.
The main concern with both procedures is a small risk of pregnancy loss. Older estimates placed this risk at about 1 in 200, but more recent data paints a reassuring picture. A cohort study found pregnancy loss rates of 1.04% after CVS and 0.79% after amniocentesis, and when compared to control groups of similar-risk pregnancies that didn’t undergo the procedures, the difference was minimal. The procedure-related loss rate, meaning losses specifically caused by the test itself, is now estimated at below 0.5% for both.
Mosaic Down Syndrome Is Harder to Detect
Most cases of Down syndrome involve a full extra copy of chromosome 21 in every cell. But in mosaic Down syndrome, only some cells carry the extra chromosome while others are normal. This form is less common and harder to catch through screening. NIPT may produce ambiguous or false negative results because the mix of normal and abnormal cells can dilute the signal in the mother’s blood.
Even with diagnostic testing, mosaicism presents challenges. The proportion of abnormal cells found in amniotic fluid doesn’t always match what’s present in the baby’s actual tissues. Karyotyping (the traditional method of visually examining chromosomes) remains the primary tool for detecting mosaicism, but combining it with additional techniques like microarray analysis or FISH improves accuracy. If mosaicism is suspected, your medical team may recommend multiple types of testing to get the clearest possible picture.
Maternal Age and Risk
The chance of having a baby with Down syndrome increases with maternal age, which is why age has historically been used as a trigger for offering diagnostic testing. At age 35, the rate is roughly 3 per 1,000 pregnancies. By age 40, it rises to about 15 per 1,000. By 48, the rate reaches approximately 71 per 1,000. However, because far more babies are born to younger parents overall, the majority of babies with Down syndrome are born to mothers under 35. Current guidelines offer screening to all pregnant people regardless of age.
What Happens After a Positive Result
If a screening test comes back positive, the next step is deciding whether to pursue diagnostic testing. A positive screening result means elevated risk, not a diagnosis. Many people in this situation choose CVS or amniocentesis to get a clear answer.
If a diagnostic test confirms Down syndrome, you’ll typically be offered genetic counseling to help you understand what the diagnosis means in practical terms. Some parents use this time to research the condition, connect with support organizations, and plan for any medical needs the baby might have after birth (since Down syndrome can involve heart conditions and other health considerations that benefit from early intervention). Some parents may consider ending the pregnancy. Others prefer not to test at all and wait until birth. There is no single right approach, and the path you choose depends on what information is most useful to you.